Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-01

Clinical Trial Update: Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated rotigotine for motor symptoms in patients with advanced Parkinson's disease and motor fluctuations with gastrointestinal dysf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Advanced Parkinson's Disease | Phase 3 | Status: TERMINATED | Results posted: 2014-08-01